Discovery and optimization of p38 inhibitors via computer-assisted drug design

J Med Chem. 2007 Aug 23;50(17):4016-26. doi: 10.1021/jm070415w. Epub 2007 Jul 20.

Abstract

Integration of computational methods, X-ray crystallography, and structure-activity relationships will be disclosed, which lead to a new class of p38 inhibitors that bind to p38 MAP kinase in a Phe out conformation.

MeSH terms

  • Animals
  • Binding Sites
  • Biological Availability
  • Computer Simulation
  • Crystallography, X-Ray
  • Drug Design
  • Lipopolysaccharides / pharmacology
  • Male
  • Mice
  • Models, Molecular*
  • Niacinamide / analogs & derivatives
  • Niacinamide / chemical synthesis
  • Niacinamide / chemistry
  • Niacinamide / pharmacology
  • Protein Kinase Inhibitors / chemical synthesis*
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Structure-Activity Relationship
  • Sulfonamides / chemical synthesis*
  • Sulfonamides / chemistry
  • Sulfonamides / pharmacology
  • Thiophenes / chemical synthesis
  • Thiophenes / chemistry
  • Thiophenes / pharmacology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / biosynthesis
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors*
  • p38 Mitogen-Activated Protein Kinases / chemistry*

Substances

  • Lipopolysaccharides
  • Protein Kinase Inhibitors
  • Sulfonamides
  • Thiophenes
  • Tumor Necrosis Factor-alpha
  • Niacinamide
  • p38 Mitogen-Activated Protein Kinases